ID | Name | Number of studies | |
|---|---|---|---|
| CL_0000115 | endothelial cell | 77 | |
| CL_0002350 | endocardial cell | 3 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
|---|---|---|---|---|---|
| SLCO2A1 | 3 | 39% ± 11% | 0 | 6 | |
| PKHD1L1 | 3 | 59% ± 28% | 1 | 2 | |
| BMX | 3 | 34% ± 7% | 1 | 3 | |
| GATA4 | 3 | 38% ± 6% | 1 | 4 | |
| SMAD6 | 3 | 31% ± 11% | 1 | 5 | |
| VWF | 3 | 49% ± 16% | 1 | 8 | |
| EMCN | 3 | 79% ± 2% | 1 | 10 | |
| PTGIS | 3 | 33% ± 8% | 2 | 7 | |
| HMCN1 | 3 | 49% ± 15% | 2 | 8 | |
| NOSTRIN | 3 | 42% ± 13% | 2 | 9 | |
| PTPRB | 3 | 41% ± 15% | 2 | 12 | |
| POSTN | 3 | 75% ± 6% | 2 | 13 | |
| CALCRL | 3 | 69% ± 6% | 2 | 14 | |
| EPHA4 | 3 | 31% ± 10% | 3 | 12 | |
| HIF3A | 3 | 44% ± 9% | 3 | 18 | |
| ENG | 3 | 78% ± 5% | 3 | 26 | |
| PLA2G5 | 3 | 45% ± 15% | 4 | 6 | |
| CGNL1 | 3 | 56% ± 11% | 4 | 17 | |
| MYRIP | 3 | 48% ± 21% | 4 | 21 | |
| TGM2 | 3 | 50% ± 7% | 4 | 24 | |
| MECOM | 3 | 62% ± 22% | 4 | 26 |
| GO_0003190 | Biological process | atrioventricular valve formation |
| GO_0060290 | Biological process | transdifferentiation |
| GO_0003289 | Biological process | atrial septum primum morphogenesis |
| GO_0035054 | Biological process | embryonic heart tube anterior/posterior pattern specification |
| GO_0061026 | Biological process | cardiac muscle tissue regeneration |
| GO_0048617 | Biological process | embryonic foregut morphogenesis |
| Cell type name | endocardial cell |
| Synonyms | endocardial endothelial cell endothelial cell of endocardium |
| Description | An endothelial cell that lines the intracavitary lumen of the heart, separating the circulating blood from the underlying myocardium. This cell type releases a number of vasoactive substances including prostacyclin, nitrous oxide and endothelin. |
| Parent | CL_0000115 |